Switzerland is spending CHF100 million ($102 million) on six new research centres, each focusing on cutting-edge areas of scientific innovation. The new arrivals will boost the number of such institutes to 22 by next year.
The new National Centres of Competence in ResearchExternal link(NCCR), designed to have a maximum shelf life of 12 years, will be set up at separate universities around Switzerland. Their focus will be spread among a variety of topics, such as combating antibiotic-resistant bacteria, researching the evolution of language, and developing CO2-neutral solutions for the chemicals industry.
The CHF100 million in funding will be topped up by an unspecified amount from education institutions and the private sector.
“The NCCRs are intended to boost Swiss research and innovation long term in major fields such as automation, antibiotics resistance and quantum technology,” the government said in a statement.
“They also help to foster the careers of young academics, promote equal opportunities and encourage knowledge and technology transfer.”
More
More
Research in Switzerland
This content was published on
With its ten universities and two institutes of technology, Switzerland is at the forefront of research in many areas.
Swiss invention: 90-year anniversary of first T-bar ski lift
This content was published on
On Monday it will be 90 years since the world’s first T-bar ski lift went into service in Davos. This Swiss invention was an instant success.
Iran summons Swiss ambassador over US and Italy arrests
This content was published on
Iran has summoned the Swiss ambassador, who represents US interests, to protest against the arrest in the US and Italy of two Iranians.
Swisscom receives greenlight for acquisition of Vodafone Italia
This content was published on
The takeover of Vodafone Italia by Swisscom is nearing completion. All relevant authorities have now approved the €8 billion (CHF7.45 billion) deal.
Novo Nordisk stock market plunge drags down Swiss device maker Ypsomed
This content was published on
The Danish pharmaceutical giant, Novo Nordisk, faced setbacks on Friday that weighed on the share price of Swiss injection device manufacturer Ypsomed.
Swiss press react to EU deal with mix of euphoria and scepticism
This content was published on
Swiss media reaction to the agreement between Switzerland and the EU varies widely. Some are celebrating, while others worry about what is to come.
Swiss Solidarity donations to tackle child abuse top CHF4 million
This content was published on
Swiss Solidarity, the humanitarian arm of the Swiss Broadcasting Corporation (SBC), has raised over CHF4 million ($4.3 million) to tackle child abuse.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Deft robot fingers give new hope for prosthetics
This content was published on
Swiss researchers have developed a novel robotic system for gripping and lifting objects that mimics the delicate action of human hand muscles to an unprecedented degree.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.